Table 2.

Inoculation route and parasite dose influences on visceral leishmaniasis outcome in susceptible BALB/c mice

Infection route	Parasite dose	Parasite strain	Liver load	Spleen load	Th1 response	Th2 response	Reference
Subcutaneous	105	LIVT-1	+	-	ND	ND	[32]
	106		+	+	ND	ND
	107		+	+	ND	ND
	103	MHOM/BR/1970/BH46	+/-	++	+	+	[33]
	105		+	+++	+	+
	107		++	++++	+	+++
	103	MHOM/IN/80/DD8	+/-	ND	+++	+	[34]
	105		+	ND	++	+
	107		+	ND	++	++
Intradermal	103	MHOM/IN/80/DD8	+	ND	+++	+	[34]
	105		++	ND	++	+
	107		++	ND	++	+
	107	MHOM/ES/92/LLM-320	+++	+++	+	+	[38]
Intraperitoneal	103	MHOM/IN/80/DD8	++	ND	++	++	[34]
	105		+++	ND	+	++
	107		+++	ND	+	+++
	107	MCAN/PT/94/IMT205	ND	+	ND	ND	[37]
Intracardiac	103	MHOM/IN/80/DD8	++	ND	++	++	[34]
	105		+++	ND	+	++
	107		++++	ND	-	+++
	107	MHOM/IN/1993/B12302	+++	++	++	++	[35]
Intravenous	105	LIVT-1	+	+	ND	ND	[32]
	106		++	+	ND	ND
	107		+++	+	ND	ND
	107	MHOM/BR/1970/BH46	+	+	+	++	[33]
	103	MCAN/ES/96/BCN150	+	+	+/-	-	[36]
	105		++	++	+/-	+/-
	106		++	+++	+	++
	104	MHOM/ES/92/LLM-320	+/-	+	ND	ND	[38]
	105		+	++	ND	ND
	106		++	+++	ND	ND
	107	MCAN/PT/94/IMT205	ND	+	ND	ND	[37]

ND not done